Stories 41 - 50 for drug rehabilitation centers

The company said its partner Sigma-Tau SpA has started a pilot study of its hepatitis B drug Zadaxin to see the drug's ability to enhance the effectiveness ...

On World AIDS Day, we are asking nine drug companies to listen to the millions without access to adequate AIDS treatment. We'll be turning up the volume: ...

In-spite of abundant literature on the epidemiology and management of PEM, focus on metabolism and therapeutic drug monitoring is lacking. ...

Yet the company hasn't been able to ship the Fabry treatment from the Allston plant, and it doesn't expect to be able to meet all demand for the drug before ...

In fact, the Food and Drug Administration (FDA) has sent several letters to Bayer HealthCare Pharmaceuticals, Inc. for what the FDA called "misleading" ...

Cambridge-based Genzyme Corp. said it has begun shipping new vials of its Cerezyme drug manufactured at the Allston plant shut down ...

“Because of what I have been through with the brain injury, four weeks in hospital and months of rehabilitation, I can no longer bear to be friends with ...

Pfizer will pay $60 million upfront to gain worldwide licensing rights to the drug, although Protalix will maintain rights in its home country of Israel. ...

Bayer says it plans to launch the drug in the country by mid-2010. The company separately reported exercising its option as per an agreement inked in ...